279 related articles for article (PubMed ID: 20701095)
1. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
2. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands.
Gibbons MD; Manne U; Carroll WR; Peters GE; Weiss HL; Grizzle WE
Laryngoscope; 2001 Aug; 111(8):1373-8. PubMed ID: 11568571
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland.
Okamura K; Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Ishibashi H; Komatsu S; Rasul AM; Sakai H
Oral Oncol; 2002 Apr; 38(3):244-50. PubMed ID: 11978546
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland tumors in children and adolescents: a clinicopathologic and immunohistochemical study of fifty-three cases.
da Cruz Perez DE; Pires FR; Alves FA; Almeida OP; Kowalski LP
Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):895-902. PubMed ID: 15183580
[TBL] [Abstract][Full Text] [Related]
6. Expression of α-smooth muscle actin in benign and malignant salivary gland tumors: An immunohistochemical study.
Ravi M; Boaz K; Natarajan S; Lewis A; Prasad M; Yellapurkar S
Indian J Pathol Microbiol; 2018; 61(4):479-484. PubMed ID: 30303133
[TBL] [Abstract][Full Text] [Related]
7. Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors.
Tadbir AA; Pardis S; Ashkavandi ZJ; Najvani AD; Ashraf MJ; Taheri A; Zadeh MA; Sardari Y
Asian Pac J Cancer Prev; 2012; 13(10):5155-9. PubMed ID: 23244127
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands.
Kiyoshima T; Shima K; Kobayashi I; Matsuo K; Okamura K; Komatsu S; Rasul AM; Sakai H
Oral Oncol; 2001 Apr; 37(3):315-22. PubMed ID: 11287288
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of the expression of fatty acid synthase and Ki-67 in salivary gland tumors.
do Prado RF; da Silva Machado AL; Colombo CE; Carvalho YR
J Oral Pathol Med; 2011 Jul; 40(6):467-75. PubMed ID: 21385214
[TBL] [Abstract][Full Text] [Related]
10. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
11. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
12. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
13. E-CADERIN, N-CADERIN, SLUG, SNAIL, and TWIST contribute to epithelial-mesenchymal transition in salivary gland tumors.
de Santana DA; Braga PR; Camillo-Coutinho CM; Freitas VS; Cury PR; Ribeiro DA; de Araújo IB; de Aquino Xavier FC; Dos Santos JN
J Oral Pathol Med; 2024 Mar; 53(3):193-200. PubMed ID: 38351435
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycans in pleomorphic adenoma and adenoid cystic carcinoma of the salivary gland.
Nakanishi K; Kawai T; Suzuki M; Shinmei M
Arch Pathol Lab Med; 1990 Dec; 114(12):1227-31. PubMed ID: 2174671
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma.
Safoura S; Mohamad E; Nosrat-Allah E; Fereshte E
J Cancer Res Ther; 2011; 7(1):23-8. PubMed ID: 21546738
[TBL] [Abstract][Full Text] [Related]
16. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical correlation of epidermal growth factor receptor and c-erbB-2 with histopathologic grading of mucoepidermoid carcinoma.
Khiavi MM; Vosoughhosseini S; Saravani S; Halimi M
J Cancer Res Ther; 2012; 8(4):586-90. PubMed ID: 23361279
[TBL] [Abstract][Full Text] [Related]
18. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
20. [Mucoepidermoid carcinomas of salivary glands: prognostic significance of immunohistochemistry. A study of 49 cases].
Santini L; Coulibaly B; Gaudart J; Turner F; Michel J; Giovanni A; Dessi P; Fakhry N
Rev Laryngol Otol Rhinol (Bord); 2012; 133(4-5):183-7. PubMed ID: 24006824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
